Aggressive organ penetration and high vector transmissibility of epidemic dengue virus-2 Cosmopolitan genotype in a transmission mouse model

PLoS Pathog. 2021 Mar 30;17(3):e1009480. doi: 10.1371/journal.ppat.1009480. eCollection 2021 Mar.

Abstract

Dengue virus (DENV) causes dengue fever and severe hemorrhagic fever in humans and is primarily transmitted by Aedes aegypti and A. albopictus mosquitoes. The incidence of DENV infection has been gradually increasing in recent years due to global urbanization and international travel. Understanding the virulence determinants in host and vector transmissibility of emerging epidemic DENV will be critical to combat potential outbreaks. The DENV serotype 2 (DENV-2), which caused a widespread outbreak in Taiwan in 2015 (TW2015), is of the Cosmopolitan genotype and is phylogenetically related to the virus strain linked to another large outbreak in Indonesia in 2015. We found that the TW2015 virus was highly virulent in type I and type II interferon-deficient mice, with robust replication in spleen, lung, and intestine. The TW2015 virus also had high transmissibility to Aedes mosquitoes and could be effectively spread in a continuous mosquitoes-mouse-mosquitoes-mouse transmission cycle. By making 16681-based mutants carrying different segments of the TW2015 virus, we identified the structural pre-membrane (prM) and envelope (E) genes as key virulence determinants in the host, with involvement in the high transmissibility of the TW2015 virus in mosquitoes. The transmission mouse model will make a useful platform for evaluation of DENV with high epidemic potential and development of new strategies against dengue outbreaks.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Culicidae / virology*
  • Dengue / virology*
  • Dengue Virus / genetics*
  • Dengue Virus / pathogenicity*
  • Disease Models, Animal
  • Genotype
  • Insect Vectors / virology*
  • Mice
  • Virulence / physiology*

Grants and funding

This study was supported by grants from the National Health Research Institutes (NHRI; IV-105-SP-03, MR-106-PP-01) and the Ministry of Science and Technology (MOST 105-2321-B-400-006) from Taiwan to G.Y.Y.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.